No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells

Therapeutic Drug Monitoring

Volumn 28, Issue 5, 2006, Pages 707-711

  Jamroziak, Krzysztof ^a   Balcerczak, Ewa ^a   Cebula, Barbara ^a   Janus, Agnieszka ^a   Mirowski, Marek ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

ABCB1; Acute myeloid leukemia; MDR1; P glycoprotein; Polymorphism

Indexed keywords

ABC TRANSPORTER; GLYCOPROTEIN P; XENOBIOTIC AGENT;

ABCB1 GENE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CANCER RISK; DNA POLYMORPHISM; EXON; FEMALE; FLOW CYTOMETRY; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MDR1 GENE; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC;

EID: 33749820746     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000245770.75097.3f     Document Type: Article

References (16)

1. Morgan GJ, Smith MT. Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults. Am J Pharmacogenomics. 2002;2:79-92.
2. Leith CP, Chen IM, Kopecky KJ, et al. Correlation of multi-drug resistance (MDR1) protein expression with dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR1-/efflux+ and MDR1+/efflux- cases. Blood. 1995;86:2329-2324.
3. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 1991;66:85-94.
4. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000;97:3473-3478.
5. Eichelbaum M, Fromm MF, Shwab M. Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther Drug Monit. 2004;26:180-185.
6. Wang D, Johnson AD, Papp AC. et al. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics. 2005;15:693-704.
7. Siegsmund M, Brinkmann U, Schaffeler E, et al. Association of the P-glycoprotein transporter MDR1 (3435C>T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol. 2002;13:1847-1854.
8. Jamroziak K, Mlynarski W, Balcerczak E, et al. Functional 3435C>T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Hematol. 2004,72:314-321.
9. Illmer T, Shuler US, Thiede C, et al. MDR gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res. 2002;62:4955-4962.
10. Kawasaki ES. Sample preparation from blood, cells, and other fluids. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds., PCR Protocols: A Guide to Methods and Applications. San Diego: Academic Press, Inc. 1990:146-152.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
12. Taipalensuu J, Tornblom H, Lindberg G, et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther. 2001;299:164-170.
13. Jamroziak K, Smolewski P, Cebula B, et al. Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia. Neoplasma. 2004;51:181-187.
14. Hitzl M, Drescher S, van der Kuip, et al. The 3435C>T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics. 2001;11:293-298.
15. Fellay J, Marzolini C, Meaden ER, et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet. 2002;359:30-36.
16. Calado RT, Falcao RP, Garcia AB, et al. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells. Haematologica. 2002;87:564-568.